Abstract The human immunodeficiency virus
Introduction
The human immunodeficiency virus (HIV) crosses through the blood-brain barrier soon after infection, resulting in reactive neuroinflammation and subsequent neuronal death (Kaul et al. 2001; Kumar et al. 2009 ). Once in the brain, HIV primarily infects microglia and astrocytes rather than neurons (Kaul et al. 2001; Gougeon and Piacentini 2009; Anthony and Bell 2008) . A subsequent cascade of inflammatory chemokines and cytokines induces excitotoxicity and neuronal loss (Kaul et al. 2001; Mattson et al. 2005) . While the presence of the virus is ubiquitous throughout the brain, higher concentrations have been observed in the striatum and cortical gray and white matter (Wiley et al. 1998; Archibald et al. 2004 ) that comprise a frontal-subcortical network. Disruption of neuronal function in these networks can result in impairments in psychomotor performance, learning, and executive function (Arendt et al. 1990; Carey et al. 2004 ; Thompson et al. 2005; Becker et al. 2011; Cardenas et al. 2009; Ances et al. 2009 Ances et al. , 2010 Stout et al. 1998; Avison et al. 2004; Cohen et al. 2010; Gongvatana et al. 2011) .
Several HIV clade subtypes have evolved with distinct genetic differences that follow geographic boundaries (Shapshak et al. 2011; Rambaut et al. 2004; Wainberg 2004) . HIV clade C (HIV-C) is the most prevalent clade worldwide and exists primarily in India, Southern Africa, and portions of North America (Wainberg 2004) . HIV clade B (HIV-B) is predominantly found in the USA and Europe. A majority of HIV research concerning neurocognitive disorders has primarily focused on HIV-B. These two HIV subtypes have distinct viral structures that may account for differences in their neurovirulence (Campbell et al. 2011; Mishra et al. 2008; Rao et al. 2008) . In animal studies, HIV-C is less virulent than HIV-B due to reductions in monocyte attraction (Rao et al. 2008) , induction of fewer pro-inflammatory cytokines (Gandhi et al. 2009 ), and decreased replication within monocytes (Constantino et al. 2011) . Additionally, animals infected with HIV-C have better cognitive performance than HIV-B-infected animals (Rao et al. 2008) .
Within humans, HIV-associated neurocognitive disorders (HAND) have been observed with both clade subtypes. However, controversy remains as the prevalence of HAND varies within these subtypes with an occurrence of 33-50 % for HIV-C (Joska et al. 2011 ) and 22-55 % for HIV-B (Heaton et al. 2010; Antinori et al. 2007) . Observed distinctions in cognitive impairment may reflect differences in sample heterogeneity or study designs that did not include comparable controls with similar cultural and educational backgrounds (Heaton et al. 2010) . Furthermore, educational and cultural differences can complicate neuropsychological assessments as most tests that have been developed are based on controls from the US population. As such, nonbehavioral biomarkers could also assist in identifying HIV-associated neuropathology according to HIV clade subtype independent of neuropsychological assessment.
Neuroimaging provides a noninvasive method to assess the effects of HIV in the brain. In general, brain integrity is affected by HIVeven in the highly active antiretroviral therapy (HAART) era Thompson et al. 2005; Becker et al. 2011; Cardenas et al. 2009; Chang et al. 2011; Stout et al. 1998; Pfefferbaum et al. 2009 ). However, most neuroimaging studies have been performed in the USA or Europe where HIV-B is most prominent. Structural changes due to HIV-B have been seen within select cortical and subcortical areas (Thompson et al. 2005; Stout et al. 1998; Archibald et al. 2004; Cardenas et al. 2009; Ances et al. 2012) . More recently, our group has demonstrated significant decreases in both cortical (gray and white matter) and subcortical (i.e., thalamus) areas in HIV-C individuals when compared to appropriate HIV− controls . Furthermore, members of our group have reported microstructural abnormalities in the white matter of HIV-C participants (Hoare et al. 2013) . However, studies comparing HIV-B and HIV-C have not been completed.
In this current study, we examined volumetric measures, laboratory values, and neuropsychological performance within HAART-naïve HIV-B and HIV-C individuals. In order to compare structural changes that occur in each cohort, HIV− controls from both regions (USA and South Africa) were included. We hypothesized that both HIV+ individuals (HIV-B and HIV-C) would have poorer cognitive performance and reductions in brain volumetrics relative to HIV− controls.
Methods

Participants
A total of 68 participants were included in this study. Participants were recruited from both the USA (n =34) and South Africa (n =34). Within each country, 17 HAART-naïve HIV+ individuals and 17 HIV− controls matched for age and education were included. Gender differences existed between the HIV-B and HIV-C groups. The HIV-B group was entirely male and a majority of the HIV-C participants were female (65 %). HIV− controls were matched regionally for gender, such that a majority of HIV− controls in the USA were male (76 %) and a majority of the HIV− controls in South Africa were female (65 %).
Participants with a history of head injury with loss of consciousness >30 min, major psychiatric disorders, opportunistic central nervous system infections, or contraindications for magnetic resonance imaging (MRI) scanning (metal implants in head, pacemakers, claustrophobia, etc.) were excluded. Consent was obtained from all participants using forms approved by the appropriate Human Research Ethics Committee in Cape Town, South Africa and by the institutional review board for the participating US-based universities. For all HIV+ participants, HIV status was confirmed through enzyme-linked immunosorbent assay, Western blot, or polymerase chain reaction. Heaps et al. 2012) . In South Africa, the HVLT-R was adjusted to ensure that items were culturally relevant by using semantically related words occurring with similar frequency in the Xhosa language compared to words used in the English version. Additionally, word choices and instructions for tests were first translated from English to Xhosa (the primary language spoken by our patient sample in South Africa) with reverse translation, Xhosa to English, and translated back to English to verify accuracy Joska et al. 2011 ).
Structural neuroimaging
In the USA, imaging was performed on a 3-T Siemens Tim Trio whole body MR scanner (Siemens AG, Erlangen Germany), with a 12-channel transmit/receive head coil. The structural images were acquired using a T1-weighted threedimensional magnetization-prepared rapid acquisition gradient echo (MP-RAGE) sequence [time of repetition (TR)= 2,400 ms, echo time (TE)=3.16 ms, inversion time (TI)= 1,000 ms, flip angle=8°, 162 slices, and voxel size=1×1× 1 mm 3 ]. All images were acquired in the sagittal plane. In South Africa, imaging was acquired on a 3-T Siemens Allegra MR scanner (Siemens AG, Erlangen Germany), with a fourchannel phased-array head coil using an identical MP-RAGE sequence as noted previously, except for TE=2.38 ms. These scans were also acquired in the sagittal plane. During these scans, participants were instructed to focus on a plus sign in the center of the screen in order to reduce movement. If excessive movement was observed, an additional structural scan was acquired.
Quantification of volumes within certain regions was completed using the Freesurfer software suite (v5.1) (Martinos Center, Harvard University, Boston, MA, USA; http://surfer. nmr.mgh.harvard.edu). Briefly, this well-validated automated software program transforms the MP-RAGE scan of an individual into a template space with the skull stripped and the brain segmented into white matter, gray matter, and ventricles. Brain regions were parcellated into subcortical and cortical regions of interest (ROI) using a surface deformation program (Fig. 1) (Fischl et al. 2002; Desikan et al. 2006; Fischl and Dale 2000) . Images from all subjects were aligned onto a common atlas (MNI305) (Fischl et al. 2002) . For this analysis, strategic ROIs analyzed included: caudate, putamen, amygdala, thalamus, hippocampus, corpus callosum, gray matter, and cortical white matter. Two trained raters independently confirmed the segmentation of these ROIs (MO and JMH) with manual edits implemented when necessary. Each volume was normalized to total intracranial volume using a least square residual regression model ).
Statistical analysis
For each ROI, the effect of HIV infection on brain volumetrics was assessed using a linear model, with the log-transformed ROI volume used as the response. The natural logarithm transformation achieves two important goals. First, it improved normality and homoscedasticity of the volumetric outcome. Second, it allowed the interpretation of the results in terms of proportional differences between groups. Specifically, if β was the regression coefficient for the HIV indicator in the analysis of the natural log-transformed volume, then exp(β) was the ratio of the mean volumes of the HIV+ and HIV− groups and exp(β)−1 was the proportional or fractional difference in mean volumes between groups. The mean here refers to the geometric mean. For HIV and other factors, we reported the effect exp(β)−1. For example, a negative effect of HIV represented volume "reduction" due to HIV and a positive effect represented volume "increase." This methodology allowed us to compare the effects of HIV clades between the two groups, even though the volumetrics of the two groups were not directly comparable. Ninety-five percent confidence intervals were also included. The linear model included HIV status (i.e., HIV+ or HIV−), region (USA vs. South Africa), and their interaction. The region effect allowed for overall volumetric differences between the USA and South Africa in the HIV− controls. The interaction between HIV status and region compared the effects of the HIV-B and HIV-C clades on brain volumes in their respective populations. The statistical presence of an interaction signified that the HIV-B and HIV-C clades had different effects on brain volumes. If this interaction was not significant (p <0.05 level), it was removed from the model, and an additive model that included HIV status and region as covariates assessed the effects of HIV, adjusting for volume differences between the South Africa and US regions among the HIV− controls. Based on these models, we reported (1) the clade effect (given by the interaction between HIV status and region) and (2) the HIV effect (differences between HIV+ and HIV− controls, when these did not differ between clades). Our analyses adjusted for gender, age, and years of education using backward model selection with a significance threshold of 0.20.
The effect of CD4 cell count on brain volumetrics within HIV+ participants was examined separately for each region using a linear model with square root-transformed CD4 cell counts as a predictor and the ROI log-transformed volume as a response. The square root transformation is typically used in the analysis of CD4 data in order to improve normality of the distribution (Ellis et al. 2011 ). We also examined for possible differences between regions in regards to the association between CD4 cell count and brain volumetrics using a similar linear model that included square root CD4 cell count, region (USA vs. South Africa), and their interaction. Similar analyses were conducted for the association between log 10 plasma HIV VL and brain volumetrics. Finally, we studied the association between duration of infection (log-transformed) and brain volumetrics for both regions using similar methods as mentioned previously for the CD4 cell count effect. For the duration of infection, we used a base 2 logarithm transformation, such that a single unit on the log 2 scale represented a doubling of time since infection.
Results
HIV-C individuals had greater compromised immune systems
Demographics for the various groups are presented in Table 1 . In general, the groups were similar with regard to age and education. HIV-C individuals had significantly lower plasma CD4 cell counts and significantly higher plasma HIV VL than HIV-B participants. The self-reported time since diagnosis (estimated duration of HIV infection) was not significantly different between the two HIV+ groups, with the mean, minimum, and maximum of 14 months (2, 14) and 17 months (5, 23) for HIV-C and HIV-B respectively (Table 1) . Fig. 1 ROIs that were evaluated for each participant included the corpus callosum (red), caudate (light blue), thalamus (green), putamen (pink), hippocampus (yellow), and amygdala (aqua). Areas of interest were overlaid onto a sagittal T1 MP-RAGE image Neuropsychological performance was lower in HIV+ individuals Significant differences on neuropsychological measurements were observed between HIV+ individuals (regardless of HIV clade subtype) and HIV− controls. In particular, both HIV-B and HIV-C individuals performed significantly worse than their HIV− control counterparts on Digit Symbol, Animal Fluency, and Trail Making Test A (Table 1) . Due to the differences in education as well as potential cultural differences that may exist between the two regions, neuropsychological measures could not be directly compared between the US and South African cohorts.
Brain volumetrics were lower in HAART-naïve HIV+ individuals compared to HIV− controls HIV+ individuals (regardless of HIV clade subtype) had significantly smaller measurements in brain volumetrics within multiple ROIs compared to HIV− controls ( Table 2 ). The thalamus, corpus callosum, hippocampus, gray matter, and cortical white matter were significantly reduced in HIV-C Values in bold indicate p <0.05; values in italics indicate trend for significance. HIV-B participants had significant reductions in gray matter compared to HIV− controls in the USA. In South Africa, HIV-C has significant reductions in gray matter, corpus callosum, white matter, thalamus, and hippocampus compared to HIV− controls. No significant clade effects were seen. Overall, HIV+ participants had significant reductions in gray matter, corpus callosum, white matter, thalamus, and hippocampus compared to HIV− controls individuals compared to the respective South African HIV− controls ( Supplementary Fig. 1 ). HIV-B individuals had a significantly smaller proportional volume only within the gray matter when compared to the HIV− controls in the USA (Table 2 and Supplementary Fig. 1 ). However, no significant differences in brain volumes were observed between HAARTnaïve HIV-B and HIV-C individuals after adjusting for demographics. Overall, these findings are reported in the mean and interquartile differences (volumetric) between the respective HIV+ and HIV− groups ( Supplementary Fig. 1 ), as well as the percent difference between groups (see Table 2 ).
Laboratory indices did not correlate with brain volumetric measures in HIV+ individuals
No significant associations were observed for plasma CD4 cell count or plasma HIV VL and brain volumetrics for each of the ROIs regardless of the HIV clade subtype (data not shown). As expected, with the matched durations of infection between the two HIV clades (Table 1) , there was no observed association between duration of HIV infection and brain volumetrics for each of the ROIs (data not shown).
Discussion
In the present study, we observed significantly smaller volumes in both subcortical (HIV-C) and cortical areas (HIV-B and HIV-C) for HIV+ individuals compared to HIV− controls. No significant differences in brain volumes were seen between HIV-B and HIV-C participants. Our study suggests that HIV-B and HIV-C are both neurovirulent and are associated with reductions in brain volumetrics and neuropsychological performance. Previous studies have suggested that both HIV-B and HIV-C diminish cognitive performance; however, animal models have suggested that HIV-C is less neurovirulent than HIV-B (Rao et al. 2008; Mishra et al. 2008) . Multiple human studies performed in the USA have demonstrated that HAND is prevalent for HIV-B and HIV-C. Neuropsychological deficits have also been observed in HIV-C human studies performed in India (Wadia et al. 2001; Yepthomi et al. 2006) and Africa (Joska et al. 2011) . However, in Africa, the prevalence of HAND is difficult to accurately assess due to the lack of established normative data that are region-specific. In this study, HIV+ individuals were more impaired, regardless of clade subtype, across multiple cognitive domains compared to HIV− controls (Table 1) . Interestingly, similar cognitive domains were affected in HIV-B and HIV-C individuals when compared to their respective HIV− control group despite using a relatively restricted battery. Although the neuropsychological tests were administered in a standardized manner, we chose not to directly compare performance between the two HIV clades considering the cultural and educational differences that exist between the countries as well as the lack of established normative neuropsychological data in South Africa.
Neuroimaging provides an objective method for assessing brain abnormalities and the magnitude of these abnormalities between HIV clades. Previous studies have demonstrated reduced volumes within the thalamus, caudate, putamen, cortical white matter, and gray matter due to HIV-B (Thompson et al. 2005; Clark et al. 2012; Towgood et al. 2012; Pfefferbaum et al. 2012; Stout et al. 1998; Ances et al. 2012; Holt et al. 2012 ) (for a review, see Holt et al. 2012) . However, only a few studies have investigated the effects of other clades besides HIV-B using neuroimaging Hoare et al. 2013) . Our group has recently shown that HIV-C individuals have smaller brain volumetric measures within the thalamus, white matter, and gray matter . The current study is a natural extension of this work as it is the first to investigate if the relative differences in brain volumes are different for HIV-B and HIV-C. We observed significant reductions in subcortical and cortical areas that were similar to previous reports in the USA and South Africa; however, no significant differences were seen between clade subtypes across ROIs (Table 2 and Supplementary Fig. 1 ). While the relative differences in HIV-C were larger for all ROIs, except the amygdala, none of the differences were significant across the clades. These findings suggest that HIV negatively impacts brain integrity for both clades despite genetic differences. These neuroimaging results appear to contradict recent literature showing that HIV-B and HIV-C impart different levels of toxicity at the cellular level (Samikkannu et al. 2011; Rao et al. 2008 Rao et al. , 2013 . Differences in neurovirulence may still occur as our study only focused on HIV+ individuals that had been infected for a relatively short period of time and were HAARTnaïve. Further, while previous studies of HIV-C toxicity focused on a defect in the Tat protein that appears to underlie reduced neuronal damage. It is possible that geographic differences exist in the conservation of this Tat protein defect. The frequency of the HIV-C Tat protein defect may be less common among individuals in South Africa than what has been previously reported among HIV+ individuals in India (Gandhi et al. 2009; Rao et al. 2013) . Nevertheless, the fact that cognitive impairments have been reported across multiple geographic regions suggests that factors other than Tat underlie compromised brain integrity associated with HIV-C (Mishra et al. 2008; Jayadev and Garden 2009; Modi et al. 2007) .
In the present study, both HIV+ participants had poorer immune function as assessed by current CD4 cell count and HIV VL. For this study, we only focused on HIV+ participants who were HAART-naïve in an attempt to reduce possible confounding effects of medications. Recently, studies have suggested that early initiation of HAART could reduce the incidence of HAND (Heaton et al. 2010; Crum-Cianflone et al. 2012) . Interestingly, there was no significant relationship between plasma HIV VL or current plasma CD4 cell count and brain volume for either HIV-B or HIV-C. These peripheral measures may not be sensitive to changes that occur within the brain. It is also possible that our small sample size may have limited ability to detect the relationship between these markers and brain abnormalities. Additionally, we did not observe a significant relationship between duration of infection and brain volumes for select ROIs. Duration of infection was estimated from self-reported time since diagnosis for the majority of HIV+ participants and may be subject to recall bias.
Our study has a few limitations. In general, a relatively small number of participants (n =17) were present within each of the groups. Years of education were significantly different between the two countries though differences in educational school systems limit direct comparisons of education such that the group difference is not as meaningful in the case of intraclade comparisons. A significant strength is that these groups are relatively well balanced with regard to age. An additional strength was that all neuroimaging studies were acquired on the same scanner manufacturer, at the same field strength, and with similar imaging acquisition. In the USA, a greater proportion of HIV+ participants were male, whereas in South Africa, more were female. While we were able to control for age and gender within each continent, additional socioeconomic differences could exist between the two continents. In particular, differences in diet, health care access, and culture are disparate between the two groups. In this sample, we could not obtain nadir CD4 cell count for the HIV-C group due to limited access to medical care, as participants were referred from various clinics. A well-matched HIV− control group from respective areas was included to mitigate some of these differences. For our analysis, we compared brain volumes to age-and sex-matched local controls within each clade and then compared the relative difference in brain volume between the HIV+ groups to account for possible regional differences. Finally, our analysis was restricted to primarily cortical and subcortical volumetrics and not cortical thickness. Future studies using cortical thickness may be beneficial for determining if clade differences exist (Thompson et al. 2005; Kallianpur et al. 2012; Ances et al. 2009; Wang et al. 2011 ). Since the current study is cross-sectional in nature, we are unable to determine if a particular HIV clade subtype augments the amount of degeneration.
In summary, this study demonstrates there are similar degrees of brain abnormalities in both HIV-B and HIV-C who were HAART-naive. These changes exist independent of typical peripheral markers such as plasma HIV VL or plasma CD4 cell count. Based on the small neuropsychological battery administered, it is evident that both HIV-B and HIV-C groups demonstrate deficits compared to their respective HIV − controls. Further longitudinal studies are needed to assess the impact of HAART on both brain imaging metrics and neuropsychological performance in these cohorts.
